177 related articles for article (PubMed ID: 1909610)
1. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.
Ross R; Miell J; Freeman E; Jones J; Matthews D; Preece M; Buchanan C
Clin Endocrinol (Oxf); 1991 Jul; 35(1):47-54. PubMed ID: 1909610
[TBL] [Abstract][Full Text] [Related]
2. Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients.
Ross RJ; Miell JP; Holly JM; Maheshwari H; Norman M; Abdulla AF; Buchanan CR
Clin Endocrinol (Oxf); 1991 Oct; 35(4):361-7. PubMed ID: 1721565
[TBL] [Abstract][Full Text] [Related]
3. Effects of season and nutrition on growth hormone and insulin-like growth factor-I in male red deer.
Webster JR; Corson ID; Littlejohn RP; Stuart SK; Suttie JM
Endocrinology; 1996 Feb; 137(2):698-704. PubMed ID: 8593820
[TBL] [Abstract][Full Text] [Related]
4. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
5. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.
Cuneo RC; Hickman PE; Wallace JD; Teh BT; Ward G; Veldhuis JD; Waters MJ
Clin Endocrinol (Oxf); 1995 Sep; 43(3):265-75. PubMed ID: 7586594
[TBL] [Abstract][Full Text] [Related]
6. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
[TBL] [Abstract][Full Text] [Related]
9. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
10. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
[TBL] [Abstract][Full Text] [Related]
11. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
Broglio F; Fubini A; Morello M; Arvat E; Aimaretti G; Gianotti L; Boghen MF; Deghenghi R; Mangiardi L; Ghigo E
Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
[TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin-like growth factor-1 modulate the lipolytic action of growth hormone by altering signal pathway linkages.
Bergan-Roller HE; Ickstadt AT; Kittilson JD; Sheridan MA
Gen Comp Endocrinol; 2017 Jul; 248():40-48. PubMed ID: 28410970
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
14. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
15. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific regulation of the growth hormone/insulin-like growth factor axis during fasting and re-feeding: Importance of muscle expression of IGF-I and IGF-II mRNA in the tilapia.
Fox BK; Breves JP; Davis LK; Pierce AL; Hirano T; Grau EG
Gen Comp Endocrinol; 2010 May; 166(3):573-80. PubMed ID: 19932110
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
Ho KY; Weissberger AJ
Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
[TBL] [Abstract][Full Text] [Related]
18. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.
Achermann JC; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1998 Nov; 49(5):639-45. PubMed ID: 10197080
[TBL] [Abstract][Full Text] [Related]
20. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
